Next-generation Sequencing Library Preparation Market Size, Share & Trends Report

Next-generation Sequencing Library Preparation Market (2026 - 2033) Size, Share & Trends Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End Use, By Region, And Segment Forecasts

Market Segmentation

Next-generation Sequencing Library Preparation Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
- Targeted Genome Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Other Sequencing Types
Next-generation Sequencing Library Preparation Product Outlook (Revenue, USD Million, 2021 - 2033)
- Reagents & Consumables
  - DNA Library Preparation Kits
  - RNA Library Preparation Kits
  - Other Reagents & Consumables
- Instruments
Next-generation Sequencing Library Preparation Application Outlook (Revenue, USD Million, 2021 - 2033)
- Drug & Biomarker Discovery
- Disease Diagnostics
  - Cancer Diagnostics
  - Reproductive Health Diagnostics
  - Infectious Disease Diagnostics
  - Other Disease Diagnostic Applications
- Others
Next-generation Sequencing Library Preparation End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals and Clinics
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Others
Next-generation Sequencing Library Preparation Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
    - Targeted Genome Sequencing
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Other Sequencing Types
  - North America Product Outlook (Revenue, USD Million, 2021 - 2033)
    - Reagents & Consumables
      - DNA Library Preparation Kits
      - RNA Library Preparation Kits
      - Other Reagents & Consumables
    - Instruments
  - North America Application Outlook (Revenue, USD Million, 2021 - 2033)
    - Drug & Biomarker Discovery
    - Disease Diagnostics
      - Cancer Diagnostics
      - Reproductive Health Diagnostics
      - Infectious Disease Diagnostics
      - Other Disease Diagnostic Applications
    - Others
  - North America End Use Outlook (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Clinics
    - Academic and Research Institutions
    - Pharmaceutical and Biotechnology Companies
    - Others
  - U.S.
    - U.S. Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - U.S. Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - U.S. Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - U.S. End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Canada
    - Canada Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Canada Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Canada Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Canada End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Mexico
    - Mexico Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Mexico Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Mexico Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Mexico End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
- Europe
  - Europe Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
    - Targeted Genome Sequencing
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Other Sequencing Types
  - Europe Product Outlook (Revenue, USD Million, 2021 - 2033)
    - Reagents & Consumables
      - DNA Library Preparation Kits
      - RNA Library Preparation Kits
      - Other Reagents & Consumables
    - Instruments
  - Europe Application Outlook (Revenue, USD Million, 2021 - 2033)
    - Drug & Biomarker Discovery
    - Disease Diagnostics
      - Cancer Diagnostics
      - Reproductive Health Diagnostics
      - Infectious Disease Diagnostics
      - Other Disease Diagnostic Applications
    - Others
  - Europe End Use Outlook (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Clinics
    - Academic and Research Institutions
    - Pharmaceutical and Biotechnology Companies
    - Others
  - UK
    - UK Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - UK Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - UK Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - UK End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Germany
    - Germany Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Germany Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Germany Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Germany End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - France
    - France Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - France Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - France Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - France End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Italy
    - Italy Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Italy Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Italy Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Italy End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Spain
    - Spain Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Spain Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Spain Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Spain End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Denmark
    - Denmark Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Denmark Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Denmark Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Denmark End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Sweden
    - Sweden Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Sweden Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Sweden Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Sweden End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Norway
    - Norway Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Norway Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Norway Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Norway End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
- Asia Pacific
  - Asia Pacific Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
    - Targeted Genome Sequencing
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Other Sequencing Types
  - Asia Pacific Product Outlook (Revenue, USD Million, 2021 - 2033)
    - Reagents & Consumables
      - DNA Library Preparation Kits
      - RNA Library Preparation Kits
      - Other Reagents & Consumables
    - Instruments
  - Asia Pacific Application Outlook (Revenue, USD Million, 2021 - 2033)
    - Drug & Biomarker Discovery
    - Disease Diagnostics
      - Cancer Diagnostics
      - Reproductive Health Diagnostics
      - Infectious Disease Diagnostics
      - Other Disease Diagnostic Applications
    - Others
  - Asia Pacific End Use Outlook (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Clinics
    - Academic and Research Institutions
    - Pharmaceutical and Biotechnology Companies
    - Others
  - Japan
    - Japan Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Japan Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Japan Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Japan End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - China
    - China Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - China Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - China Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - China End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - India
    - India Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - India Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - India Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - India End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - South Korea
    - South Korea Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - South Korea Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - South Korea Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - South Korea End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Australia
    - Australia Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Australia Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Australia Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Australia End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Thailand
    - Thailand Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Thailand Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Thailand Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Thailand End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
- Latin America
  - Latin America Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
    - Targeted Genome Sequencing
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Other Sequencing Types
  - Latin America Product Outlook (Revenue, USD Million, 2021 - 2033)
    - Reagents & Consumables
      - DNA Library Preparation Kits
      - RNA Library Preparation Kits
      - Other Reagents & Consumables
    - Instruments
  - Latin America Application Outlook (Revenue, USD Million, 2021 - 2033)
    - Drug & Biomarker Discovery
    - Disease Diagnostics
      - Cancer Diagnostics
      - Reproductive Health Diagnostics
      - Infectious Disease Diagnostics
      - Other Disease Diagnostic Applications
    - Others
  - Latin America End Use Outlook (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Clinics
    - Academic and Research Institutions
    - Pharmaceutical and Biotechnology Companies
    - Others
  - Brazil
    - Brazil Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Brazil Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Brazil Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Brazil End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Argentina
    - Argentina Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Argentina Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Argentina Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Argentina End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
- MEA
  - MEA Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
    - Targeted Genome Sequencing
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Other Sequencing Types
  - MEA Product Outlook (Revenue, USD Million, 2021 - 2033)
    - Reagents & Consumables
      - DNA Library Preparation Kits
      - RNA Library Preparation Kits
      - Other Reagents & Consumables
    - Instruments
  - MEA Application Outlook (Revenue, USD Million, 2021 - 2033)
    - Drug & Biomarker Discovery
    - Disease Diagnostics
      - Cancer Diagnostics
      - Reproductive Health Diagnostics
      - Infectious Disease Diagnostics
      - Other Disease Diagnostic Applications
    - Others
  - MEA End Use Outlook (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Clinics
    - Academic and Research Institutions
    - Pharmaceutical and Biotechnology Companies
    - Others
  - South Africa
    - South Africa Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - South Africa Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - South Africa Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - South Africa End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Saudi Arabia
    - Saudi Arabia Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Saudi Arabia End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - UAE
    - UAE Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - UAE Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - UAE Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - UAE End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others
  - Kuwait
    - Kuwait Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
      - Targeted Genome Sequencing
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Other Sequencing Types
    - Kuwait Product Outlook (Revenue, USD Million, 2021 - 2033)
      - Reagents & Consumables
        
        DNA Library Preparation Kits
        
        RNA Library Preparation Kits
        
        Other Reagents & Consumables
      - Instruments
    - Kuwait Application Outlook (Revenue, USD Million, 2021 - 2033)
      - Drug & Biomarker Discovery
      - Disease Diagnostics
        
        Cancer Diagnostics
        
        Reproductive Health Diagnostics
        
        Infectious Disease Diagnostics
        
        Other Disease Diagnostic Applications
      - Others
    - Kuwait End Use Outlook (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Clinics
      - Academic and Research Institutions
      - Pharmaceutical and Biotechnology Companies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments